Latest Adverse effect Stories
The Pradaxa Resource Center is the Web’s largest source for information on Pradaxa research, side effects and legal news. Visit http://www.Pradaxa-lawsuits.org Orlando, FL (PRWEB) May 09, 2012 The Pradaxa Resource Center, a patient advocacy group, is alerting patients taking the atrial fibrillation drug Pradaxa that recent information has related the drug to serious or fatal internal bleeding, and several victims have already filed lawsuits for injury or death. If you have questions...
According to court documents, on April 18th, 2012, the Accutane side effects lawsuit filed by Alton Herbert was transferred to the current Accutane Multi District Litigation (MDL 1626) in the Middle District of Florida. Herbert filed the lawsuit on January 12th, 2012, in the U.S. District Court for the Eastern District of Louisiana (case no. ATL-L-5981-11-MT) claiming that, after taking the generic Accutane “Claravis”, he was diagnosed with inflammatory bowel disease (Crohn's...
CHICAGO, May 8, 2012 /PRNewswire/ -- Adverse events with PCA pumps may occur even without an error being committed by attending healthcare professionals. As Frank Federico, RPh (Executive Director at the Institute for Healthcare Improvement) points out, "Many patients may experience harm even with appropriate dosing of narcotics. This is a critical point for patients, their families and their caregivers to know -- a patient may experience respiratory depression, leading to death,...
OTTAWA, May 7, 2012 /CNW/ - Health Canada is informing Canadians of a labelling update for the prescription drug Cipralex (the brand name of the drug escitalopram) regarding a dose-related risk of abnormal heart rhythms. Cipralex is used to treat depression and belongs to a family of drugs known as Selective Serotonin Reuptake Inhibitors (SSRIs). Clinical trial data has shown that Cipralex can cause electrical changes in the heart known as QT interval prolongation. These...
The US Food and Drug Administration (FDA) voted on Friday to approve a new drug to treat erectile dysfunction (ED), various media outlets have reported. The medication, Stendra (genetic name: avanafil), is produced by California-based pharmaceutical company Vivus Inc. and is the first product from that company to receive FDA approval, according to Jennifer Corbett Dooren of the Wall Street Journal. Like Viagra, Cialis, and Levitra, Stendra is a phosphodiesterase type 5 (PDE-5) inhibitor...
The Pradaxa Lawyers Special Report details homorrhagic stroke, gastrointestinal bleeding, internal bleeding and heart attack concerns related to the drug. The Federal Drug Administration has opened an investigation concerning Pradaxa side effects. St. Louis, MO (PRWEB) April 26, 2012 SL Chapman law firm has released a FREE Special Report on the drug Pradaxa® titled “7 Things You Must Know About Pradaxa Complications.” Firm Founding Partner Bradley Lakin said, “We’ve created...
SHIRLEY, N.Y., April 24, 2012 /PRNewswire/ -- American Regent is conducting a nationwide voluntary recall to the Retail/Hospital level of the following product: Epinephrine Injection, USP, 1:1000, 1 mL AmpulesNDC #0517-1071-25 Lot #1395, Exp Date: July 2012 PLEASE NOTE: This recall, initiated on April 24, 2012 to the Retail/Hospital Level, is for lot #1395 only. No other lot or sizes of Epinephrine Injection, USP are subject to this voluntary recall. American Regent is...
TITUSVILLE, N.J., April 24, 2012 /PRNewswire/ -- It lies within the compact folded rectangle that accompanies prescription medicines. In black and white on paper, it follows prescription medicine advertisements in magazines and newspapers. Known as patient information, it is frequently part of the U.S. Food and Drug Administration (FDA) approved labeling for prescription medicines. To view the multimedia assets associated with this release, please click:...
The Consumer Justice Foundation, a for-profit corporation whose Web site URL can be found at http://www.sideeffectsrx.com, is a team of professional consumer advocates who provide free informational online resources regarding the potential dangers of certain prescription medications. The CJF hereby alerts the public that Health Canada has issued a statement linking the use of Actos to an increased risk of bladder cancer and that the labeling on the packages of this drug will include a...
Comments to FDA Stress Need for Clinical Trials, Restraint for Interchangeability Designations, and Unique Names for Biosimilar Products WASHINGTON, April 16, 2012 /PRNewswire-USNewswire/ -- In response to the U.S. Food and Drug Administration's (FDA) draft guidance on the approval of biosimilar medicines, the Alliance for Safe Biologic Medicines (ASBM) submitted comments to the FDA that outlined recommended steps to ensure that patient safety is at the forefront of the biosimilars...
